On January 13, 2025, Thomas Bures was appointed to serve as the Chief Accounting Officer of Bruker Corporation, effective immediately. Mr. Bures, age 50, has more than 20 years of finance experience and has spent the last several years managing finance organizations within the healthcare and life sciences industry. Mr. Bures was most recently the Senior Vice President and Chief Financial Officer of Pieris Pharmaceuticals (formerly listed on Nasdaq: PIRS) from October 2021 to December 2024 and before that, he served in the role of Vice President, Finance since December 2017.
Prior to that position, he served as the Vice President and Corporate Controller of Genocea Biosciences Inc. (formerly listed on Nasdaq: GNCA) since 2015 and was responsible for the financial reporting, accounting, tax, treasury and insurance functions. Before joining Genocea, Mr. Bures worked for five years at PAREXEL International Corporation (formerly listed on Nasdaq: PRXL), most recently as the Vice President and Assistant Controller. He was responsible for financial reporting, internal controls, and GAAP and statutory accounting for all legal entities.
He started his career in Ernst and Young?s audit practice in 1996 and served multinational clients in the retail, manufacturing and banking industries. Mr. Bures received his B.A. in Accounting and Finance from the College of the Holy Cross.
